Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China
· Delayed Price · Currency is CNY 31.76
+0.05 (0.16%)
Last updated: May 21, 2025
SHA:688139 Revenue
Qingdao Haier Biomedical Co.,Ltd had revenue of 688.99M CNY in the quarter ending March 31, 2025, with 0.30% growth. This brings the company's revenue in the last twelve months to 2.29B, up 0.21% year-over-year. In the year 2024, Qingdao Haier Biomedical Co.,Ltd had annual revenue of 2.28B with 0.13% growth.
Revenue (ttm)
2.29B
Revenue Growth
+0.21%
P/S Ratio
4.31
Revenue / Employee
814.36K
Employees
2,807
Market Cap
9.85B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |